Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-097060

Chief Financial Officer gave up 13,048 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Myszkowski Kenneth Allen · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-02-06 Shares withheld for taxes : show line 1 in the form −13,048 $3.46 $45,146 121,952 D
Loading xslF345X03/doc4.xml…